PMLBCL is a subtype of diffuse large B-cell lymphoma (DLCL), recently recognised as a clinical–pathological entity (Harris et al, 1994). It accounts for a percentage between 6 and 13% of DLCLs (Falini ...
Combined immuno-chemotherapy (R-FCM) results in superior remission rates and overall survival in recurrent follicular and mantle cell lymphoma: Follow-up of a prospective randomized trial of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results